178 related articles for article (PubMed ID: 28161379)
1. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K
Urology; 2017 May; 103():214-217. PubMed ID: 28161379
[TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
[TBL] [Abstract][Full Text] [Related]
3. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
Kim SR; Moon YJ; Kim SK; Bai SW
Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
[TBL] [Abstract][Full Text] [Related]
4. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder.
Ciftci S; Ozkurkcugil C; Yilmaz H; Ustuner M; Yavuz U; Yuksekkaya M; Cekmen MB
Int Urogynecol J; 2016 Feb; 27(2):275-80. PubMed ID: 26310546
[TBL] [Abstract][Full Text] [Related]
6. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
Liu HT; Kuo HC
Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
[TBL] [Abstract][Full Text] [Related]
7. Could urinary nerve growth factor and bladder wall thickness predict the treatment outcome of children with overactive bladder?
Huseynov A; Telli O; Haciyev P; Okutucu TM; Akinci A; Ozkidik M; Erguder I; Fitoz S; Burgu B; Soygur T
Int Braz J Urol; 2022; 48(3):553-560. PubMed ID: 35373950
[TBL] [Abstract][Full Text] [Related]
8. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
[TBL] [Abstract][Full Text] [Related]
9. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
[TBL] [Abstract][Full Text] [Related]
10. Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics.
Cho KJ; Kim HS; Koh JS; Kim JC
Int Urogynecol J; 2013 Feb; 24(2):325-30. PubMed ID: 22717785
[TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor in women with overactive bladder syndrome.
Liu HT; Chen CY; Kuo HC
BJU Int; 2011 Mar; 107(5):799-803. PubMed ID: 20804479
[TBL] [Abstract][Full Text] [Related]
12. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.
Wang LW; Han XM; Chen CH; Ma Y; Hai B
Int Urol Nephrol; 2014 Feb; 46(2):341-7. PubMed ID: 23982767
[TBL] [Abstract][Full Text] [Related]
13. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
Sheng W; Zhang H; Ruth KH
Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
[TBL] [Abstract][Full Text] [Related]
14. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
Liu HT; Chancellor MB; Kuo HC
BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
[TBL] [Abstract][Full Text] [Related]
15. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
[TBL] [Abstract][Full Text] [Related]
17. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
Yokoyama T; Kumon H; Nagai A
Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
[TBL] [Abstract][Full Text] [Related]
18. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
[TBL] [Abstract][Full Text] [Related]
19. Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children.
Colic M; Rogic D; Lenicek Krleza J; Kozmar A; Stemberger Maric L; Abdovic S
Biochem Med (Zagreb); 2022 Oct; 32(3):030706. PubMed ID: 36277428
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
Kuo HC; Liu HT; Chancellor MB
Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
